IRIS
LAGHI PASINI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.190
EU - Europa 7.349
AS - Asia 1.251
OC - Oceania 15
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 5
AN - Antartide 1
Totale 17.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.161
GB - Regno Unito 2.375
IE - Irlanda 1.373
CN - Cina 1.024
SE - Svezia 828
UA - Ucraina 800
IT - Italia 617
DE - Germania 570
FR - Francia 405
FI - Finlandia 218
VN - Vietnam 111
ES - Italia 47
BE - Belgio 34
IN - India 33
RU - Federazione Russa 31
TR - Turchia 27
CA - Canada 23
TH - Thailandia 17
NL - Olanda 15
AU - Australia 12
EU - Europa 11
GR - Grecia 11
BR - Brasile 7
JP - Giappone 7
HK - Hong Kong 5
IL - Israele 5
IR - Iran 5
HR - Croazia 4
PL - Polonia 4
ID - Indonesia 3
KZ - Kazakistan 3
MA - Marocco 3
MX - Messico 3
NZ - Nuova Zelanda 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
CL - Cile 2
CY - Cipro 2
PE - Perù 2
RS - Serbia 2
SG - Singapore 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
ZA - Sudafrica 1
Totale 17.836
Salva come PNG Salva come JPEG
Città #
Southend 2.221
Fairfield 1.470
Dublin 1.344
Ashburn 785
Chandler 734
Woodbridge 679
Jacksonville 637
Wilmington 570
Menlo Park 535
Seattle 520
Houston 508
Cambridge 464
Ann Arbor 395
Siena 307
Princeton 264
Beijing 242
Nanjing 231
Dong Ket 111
Dearborn 109
San Diego 95
Helsinki 94
New York 94
Boardman 93
San Mateo 91
Nanchang 82
Shenyang 56
Shanghai 51
Málaga 46
Hebei 40
Tianjin 40
Venezia 39
Florence 36
Kunming 36
Brussels 34
Düsseldorf 31
Jiaxing 29
Lancaster 29
Jinan 27
Changsha 24
Izmir 24
Norwalk 24
San Francisco 24
Falls Church 21
London 19
Hefei 18
Washington 18
Guangzhou 17
Mestre 16
Toronto 16
Ningbo 15
Redwood City 15
Zhengzhou 15
Lappeenranta 13
Los Angeles 12
Pune 12
Hangzhou 11
Fremont 10
Lanzhou 10
Caserta 9
Changchun 9
Rome 9
Taizhou 9
Tappahannock 8
Chicago 7
Delhi 7
Fuzhou 7
Paris 7
Philadelphia 7
Hounslow 6
Phoenix 6
Sacramento 6
Auburn Hills 5
Canberra 5
Milan 5
Ottawa 5
Petah Tikva 5
Prato 5
Renton 5
Rufina 5
São Paulo 5
Amsterdam 4
Bari 4
Hong Kong 4
Modena 4
Saint Petersburg 4
Wuhan 4
Zagreb 4
Anguillara Sabazia 3
Ascoli Piceno 3
Athens 3
Campi Bisenzio 3
Chengdu 3
Chiswick 3
Edinburgh 3
Islington 3
Kilburn 3
Melbourne 3
Monte San Savino 3
New Bedfont 3
Newark 3
Totale 13.712
Salva come PNG Salva come JPEG
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 274
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 238
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 231
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 224
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 222
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 219
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 209
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 206
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 203
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 198
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 198
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 196
Torsades de Pointes in patients with polymyalgia rheumatica 195
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 188
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 186
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 177
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 172
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 170
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 169
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 167
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series. 165
QTc interval prolongation during infusion with dipyridamole or adenosine 164
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 162
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 157
Connective tissue diseases and cardiac rhythm disorders: an overview 156
Statins and the joint: multiple targets for a global protection? 156
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 155
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 153
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 147
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 146
The role of P2X7 receptors in tissue fibrosis: a brief review 146
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 145
null 145
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 145
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases. 144
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 143
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 143
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 142
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 140
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 140
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 139
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives. 139
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 139
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 138
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 138
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 137
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 135
Evidence of an adenosine-dependent mechanism in the hypotensive effect of L-arginine in man 134
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 134
Heart failure and chronic kidney disease in a registry of internal medicine wards 134
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation. 134
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 134
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 133
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 133
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. 132
Modulation of P2X7 receptor during inflammation in multiple sclerosis 131
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 130
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 130
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. 129
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 129
Peripheral neuropathy associated with ischemic vascular disease of the lower limbs 129
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 129
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 128
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 128
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 126
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 126
null 126
Homocysteine and Raynaud’s phenomenon: a review. 126
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 124
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 123
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 122
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 122
null 122
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids 122
null 122
Familial Mediterranean fever diagnosed in an elderly patient 120
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 119
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 119
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 118
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 117
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 116
Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease 116
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 115
Human rheumatoid synoviocytes express functional P2X7 receptors 114
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 114
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra. 113
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 113
Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. 113
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. 112
Pathogenesis of the novel autoimmune-associated long-QT syndrome 112
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 112
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates. 111
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 111
Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment. 110
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 109
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 108
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 108
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 107
Photopheresis immunomodulation after heart transplantation. 106
Haemodynamics, rheology and mechanism of action of iloprost in man 106
Totale 14.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.034 0 0 0 0 0 0 0 0 0 0 531 503
2019/20204.099 475 155 258 629 255 366 421 523 328 346 122 221
2020/20212.793 140 304 93 281 131 346 111 371 285 261 229 241
2021/20222.063 146 272 128 171 135 58 102 104 113 178 206 450
2022/20232.698 167 243 391 383 245 544 70 191 289 64 61 50
2023/20241.984 98 31 168 103 103 631 718 57 22 51 2 0
Totale 18.083